Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.

Arzneimittel-Forschung - 1 Jan 2004

Uckun Fatih M, Pendergrass Sharon, Qazi Sanjive, Venkatachalam Taracad K

Abstract excerpt

The in vitro activity profile of stampidine (CAS 217178-62-6, STAMP) was examined against clinical isolates of HIV-1. In a side-by-side comparison against 10 zidovudine-sensitive clinical HIV-1 isolates, STAMP was 100-fold more potent than stavudine (CAS 3056-17-5) and twice as effective as zidov...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV
Share to Lamivudine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neutrophils

Share to Reverse Transcriptase Inhibitors

Share to Stavudine

Share to Viral Plaque Assay

Share to Zidovudine

Source

Identifiers

PMID: 14979612
DOI: 10.1055/s-0031-1296939

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14979612-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.PMID 14979612Read ↗

Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.Semantic proximity Read ↗

Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.Semantic proximity Read ↗

In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.Semantic proximity Read ↗

SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2.Semantic proximity Read ↗

Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.Semantic proximity Read ↗

2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.Semantic proximity Read ↗

Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.Semantic proximity Read ↗

In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.